Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.27 USD | -0.48% | -16.50% | -8.30% |
Apr. 11 | Craig-Hallum Starts Harrow With Buy Rating, $24 Price Target | MT |
Mar. 22 | B. Riley Securities Adjusts Harrow Health's Price Target to $26 From $30, Maintains Buy Rating | MT |
Evolution of the average Target Price on Harrow, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Harrow, Inc.
Craig-Hallum | |
B. Riley | |
Lake Street | |
Aegis Capital |
EPS Revisions
- Stock Market
- Equities
- HROW Stock
- Consensus Harrow, Inc.